73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
More aggressive treatment doesn't impact quality of life for metastatic colorectal cancer patients, says new study

More aggressive treatment doesn't impact quality of life for metastatic colorectal cancer patients, says new study

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNewresearchin the October 2023 issue ofJournal of the National Comprehensive Cancer Networkfinds that

More aggressive treatment doesn't impact quality of life for metastatic colorectal cancer patients, says new study

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNewresearchin the October 2023 issue ofJournal of the National Comprehensive Cancer Networkfinds that
Study finds earlier mammograms for women with family history of breast cancer may not be needed

Study finds earlier mammograms for women with family history of breast cancer may not be needed

by Stephanie Winn,UC DavisCredit: Unsplash/CC0 Public DomainA new study released in the journalCancerreconsiders guidelines for when to start screening with mammograms if a woman has

Study finds earlier mammograms for women with family history of breast cancer may not be needed

by Stephanie Winn,UC DavisCredit: Unsplash/CC0 Public DomainA new study released in the journalCancerreconsiders guidelines for when to start screening with mammograms if a woman has
T-cell interactions vary between tumor microenvironments

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar
New thesis on prognostication for patients with myelodysplastic syndrome

New thesis on prognostication for patients with myelodysplastic syndrome

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainMaria Creignou from the Hematology Unit (HERM) at the Department of Medicine, Huddinge (MedH) is defending her thesis: "Improving pro

New thesis on prognostication for patients with myelodysplastic syndrome

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainMaria Creignou from the Hematology Unit (HERM) at the Department of Medicine, Huddinge (MedH) is defending her thesis: "Improving pro
Researchers identify key metabolic regulators of drug resistance in the fight against pancreatic cancer

Researchers identify key metabolic regulators of drug resistance in the fight against pancreatic cancer

by Rebecca Brierley,University at BuffaloGraphical abstract. Credit:Molecular & Cellular Proteomics(2022). DOI: 10.1016/j.mcpro.2022.100409Researchers from the University at Buff

Researchers identify key metabolic regulators of drug resistance in the fight against pancreatic cancer

by Rebecca Brierley,University at BuffaloGraphical abstract. Credit:Molecular & Cellular Proteomics(2022). DOI: 10.1016/j.mcpro.2022.100409Researchers from the University at Buff
Peripheral surrogates of tumor burden to guide therapeutic strategies for HPV-associated malignancies

Peripheral surrogates of tumor burden to guide therapeutic strategies for HPV-associated malignancies

by Impact Journals LLCTumor intrinsic and extrinsic factors in the periphery that can serve as proxies of tumor burden. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28487A new review

Peripheral surrogates of tumor burden to guide therapeutic strategies for HPV-associated malignancies

by Impact Journals LLCTumor intrinsic and extrinsic factors in the periphery that can serve as proxies of tumor burden. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28487A new review
Shortage of vital children's cancer drug stirs fear and outrage

Shortage of vital children's cancer drug stirs fear and outrage

by Marie McCulloughCredit: CC0 Public DomainA critical shortage of a chemotherapy used to treat most childhood cancers has galvanized oncologists and parents of sick children.The U.S.medical com

Shortage of vital children's cancer drug stirs fear and outrage

by Marie McCulloughCredit: CC0 Public DomainA critical shortage of a chemotherapy used to treat most childhood cancers has galvanized oncologists and parents of sick children.The U.S.medical com
PET/MRI found to accurately classify prostate cancer patients, offer potential to avoid unnecessary biopsies

PET/MRI found to accurately classify prostate cancer patients, offer potential to avoid unnecessary biopsies

bySociety of Nuclear MedicineCredit:Journal of Nuclear Medicine(2024). DOI: 10.2967/jnumed.123.266742PET/MRI can improve diagnostic accuracy for prostate cancer patients and help avo

PET/MRI found to accurately classify prostate cancer patients, offer potential to avoid unnecessary biopsies

bySociety of Nuclear MedicineCredit:Journal of Nuclear Medicine(2024). DOI: 10.2967/jnumed.123.266742PET/MRI can improve diagnostic accuracy for prostate cancer patients and help avo
Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouragin

Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouragin
Study reveals pathways for aggressive prostate cancer subtype

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati
Cancer in Europe: more cases but fewer deaths

Cancer in Europe: more cases but fewer deaths

Credit: CC0 Public DomainThe number of cancer cases has continued to rise across Europe, however mortality rates from the disease have fallen, according to the World Health Organization's "Eu

Cancer in Europe: more cases but fewer deaths

Credit: CC0 Public DomainThe number of cancer cases has continued to rise across Europe, however mortality rates from the disease have fallen, according to the World Health Organization's "Eu
Boosting the effects of a particular microRNA may benefit patients with cervical cancer

Boosting the effects of a particular microRNA may benefit patients with cervical cancer

by WileyHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress to invasive cancer

Boosting the effects of a particular microRNA may benefit patients with cervical cancer

by WileyHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress to invasive cancer